1

Rising Demand for Somatostatin Analogs in Endocrine Tumor Treatment

News Discuss 
Introduction The global Somatostatin Analogs (SSA) market is witnessing strong growth due to the rising prevalence of rare hormonal disorders such as acromegaly, Cushing’s syndrome, and neuroendocrine tumors (NETs). These synthetic peptide drugs mimic the natural hormone somatostatin and help in inhibiting the secretion of various hormones, making them highly effective for symptom co... https://alignstrategicimperative.com/industry/somatostatin-analogs-market/

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story